FindTrial
Sign In

Effect of different depths of microneedling with tranexamic acid in melasma

Comparative efficacy of topical tranexamic acid with different depths of microneedling in melasma - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061450
Enrollment
40
Registered
2024-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: dermarolling with 10% tranexamic acid solution: split face study with 1.5 mm dermaroller along with 10% tranexamic acid on one side of face at 0,2,4,6 weeks and follow up at 10 weeks Co

Sponsors

Department of Dermatology government medical college and hospital chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: nil

Exclusion criteria

Exclusion criteria: Patients with known bleeding diathesis. Patient taking anticoagulants, estrogen, progesterone, and antiandrogens. Pregnant and lactating mothers. Patients with any systemic illness

Design outcomes

Primary

MeasureTime frame
To calculate and compare hemiMASI of both sides of face at each visit to assess the melasmaTimepoint: 0,2,4,6,10 weeks—

Secondary

MeasureTime frame
side effects of dermarolling will be assessed & compared on both sides of face at 0,2,4,6,10 weeksTimepoint: baseline 2 weeks 4 weeks 6 weeks 4 weeks follow up—

Countries

India

Contacts

Public ContactProf GP Thami

government medical college and hospital Chandigarh

thamigp@gmail.com9646121544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026